These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1538726)

  • 1. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Hubbard RC; McElvaney NG; Birrer P; Shak S; Robinson WW; Jolley C; Wu M; Chernick MS; Crystal RG
    N Engl J Med; 1992 Mar; 326(12):812-5. PubMed ID: 1538726
    [No Abstract]   [Full Text] [Related]  

  • 2. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where we are now with rhDNase.
    Geddes DM; Shah PL
    Lancet; 1999 May; 353(9166):1727. PubMed ID: 10347981
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ; Hamilton SA
    J Biopharm Stat; 2000 Aug; 10(3):287-97. PubMed ID: 10959912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Rubin BK
    N Engl J Med; 1992 Aug; 327(8):571. PubMed ID: 1635583
    [No Abstract]   [Full Text] [Related]  

  • 7. New treatment for cystic fibrosis.
    Kuhn RJ
    Am Pharm; 1994 Feb; NS34(2):16-8. PubMed ID: 8166040
    [No Abstract]   [Full Text] [Related]  

  • 8. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
    Ranasinha C; Assoufi B; Shak S; Christiansen D; Fuchs H; Empey D; Geddes D; Hodson M
    Lancet; 1993 Jul; 342(8865):199-202. PubMed ID: 8100928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
    Suri R; Wallis C; Bush A; Thompson S; Normand C; Flather M; Grieve R; Metcalfe C; Lees B
    Health Technol Assess; 2002; 6(34):iii, 1-60. PubMed ID: 12583821
    [No Abstract]   [Full Text] [Related]  

  • 13. Dornase alfa in early cystic fibrosis lung disease.
    Robinson PJ
    Pediatr Pulmonol; 2002 Sep; 34(3):237-41. PubMed ID: 12203856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
    Wilmott RW; Amin RS; Colin AA; DeVault A; Dozor AJ; Eigen H; Johnson C; Lester LA; McCoy K; McKean LP; Moss R; Nash ML; Jue CP; Regelmann W; Stokes DC; Fuchs HJ
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
    Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA
    Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New pharmacological approaches: rhDNase].
    Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
    Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dornase alfa approved for use by cystic fibrosis patients.
    Am J Hosp Pharm; 1994 Apr; 51(7):869-70. PubMed ID: 8017432
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
    McLaughlin AM; McGrath E; Barry R; Egan JJ; Gallagher CG
    Clin Respir J; 2008 Apr; 2(2):123-6. PubMed ID: 20298317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
    Fiel SB; Fuchs HJ; Johnson C; Gonda I; Clark AR
    Chest; 1995 Jul; 108(1):153-6. PubMed ID: 7606951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.